Antibody Therapeutics
Last updated ISSN 2516-4236
Antibody Therapeutics is published by Oxford University Press in medicine. It is open access. The article processing charge is $2,822.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Antibody Therapeutics is — and show you journals like it.
What it publishes
Recent work in Antibody Therapeutics concentrates on these topics, taken from its published record rather than from its own description:
- Monoclonal and Polyclonal Antibodies Research
- CAR-T cell therapy research
- Protein purification and stability
- HER2/EGFR in Cancer Research
- SARS-CoV-2 and COVID-19 Research
- Glycosylation and Glycoproteins Research
- Immunotherapy and Immune Responses
- Viral Infectious Diseases and Gene Expression in Insects
- vaccines and immunoinformatics approaches
- Transgenic Plants and Applications
Key facts
| Publisher | Oxford University Press |
|---|---|
| ISSN | 2516-4236 |
| Subject area | Medicine |
| Access | Open access |
| Article processing charge | $2,822 |
| Indexed in | Scopus · DOAJ |
| Articles published | 295 |
| Publishing since | 2011 |
| Journal website | academic.oup.com/abt |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Antibody Therapeutics
Other established journals in medicine, if this one is not the right home for your paper: